01 (TIARAMIDE HCL) GENERAL PROCEDURES (1)
02 7 ACA-A48 (1)
03 CEFAZOLIN (1)
04 CEFAZOLIN SODIUM (STERILE) (1)
05 CEFIXIME (1)
06 CEFOTETAN (1)
07 CEPHALOSPORIN (ORAL) (FK482 CEFDINIR, CI-983) (1)
08 CEPHALOSPRIN C FERMENTATION AND RECOVERY IN OSAKA, JAPAN. (1)
09 FACILITY IN TOYOMA, JAPAN (1)
10 FACILITY LOCATED IN NAGOYA, JAPAN (1)
11 FACILITY LOCATED IN OSAKA, JAPAN (1)
12 FAMOTIDINE (2)
13 FK 788 DRUG SUBSTANCE (1)
14 FK 881 DRUG SUBSTANCE (1)
15 FK 960 (1)
16 FK-037 DRUG SUBSTANCE (INJECTABLE CEPHALOSPORIN) (1)
17 FK-866 DRUG SUBSTANCE (1)
18 FK117 (1)
19 FK1706 (1)
20 FK317 (1)
21 FK330 DRUG SUBSTANCE (1)
22 FK366 ALDOSE REDUCTASE INHIBITOR (1)
23 FK463 DRUG SUBSTANCE (1)
24 FK506 (FK900506) DOSAGE FORMS (1)
25 FK555 DRUG SUBSTANCE (1)
26 FK778 DRUG SUBSTANCE (1)
27 FK8453 DRUG SUBSTANCE (1)
28 FK962 (1)
29 FK973 DRUG SUBSTANCE AND DRUG PRODUCT IN AICHI & OSAKA, JAPAN (1)
30 FORMOTEROL FUMARATE (1)
31 NILVADIPINE (1)
32 NILVADIPINE (FK 235,FR 34235) (1)
33 OXY-COMPOUND AN INTERMEDIATE TO PURIFIED CEFTIZOXIME (1)
34 RHIZOXIN (1)
35 STERILE CEFAZOLIN SODIUM (1)
36 SYNTHESIS OF PYRROINITRIN (1)
37 TACROLIMUS (FK506) DRUG SUBSTANCE (1)
38 TAMOXIFEN CITRATE (1)
39 TAMSULOSIN HYDROCHLORIDE (2)
40 VANCOMYCIN HYDROCHLORIDE (1)
41 YM087 DRUG SUBSTANCE (1)
42 ZOTEPINE DRUG SUBSTANCE (1)
01 ASTELLAS IRELAND CO LTD (2)
02 ASTELLAS PHARMA GMBH (1)
03 ASTELLAS PHARMA INC (20)
04 FUJISAWA DEUTSCHLAND GMBH (1)
05 FUJISAWA PHARMACEUTICAL CO (1)
06 FUJISAWA PHARMACEUTICAL CO LTD (19)
01 Japan (44)
01 Active (3)
02 Inactive (41)
01 Blank (44)